These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 15739758)

  • 1. Poststroke depression: psychopharmacological considerations.
    Antai-Otong D
    Perspect Psychiatr Care; 2004; 40(4):167-70. PubMed ID: 15739758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Toxic tricyclic drug plasma level caused by fluoxetine].
    Hambrecht M
    Psychiatr Prax; 1995 Nov; 22(6):252-3. PubMed ID: 8570758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoxetine-imipramine interaction.
    Leroi I; Walentynowicz MA
    Can J Psychiatry; 1996 Jun; 41(5):318-9. PubMed ID: 8793156
    [No Abstract]   [Full Text] [Related]  

  • 4. Fluoxetine in depressed patients with renal failure and in depressed patients with normal kidney function.
    Levy NB; Blumenfield M; Beasley CM; Dubey AK; Solomon RJ; Todd R; Goodman A; Bergstrom RR
    Gen Hosp Psychiatry; 1996 Jan; 18(1):8-13. PubMed ID: 8666216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Escitalopram population pharmacokinetics in people living with human immunodeficiency virus and in the psychiatric population: Drug-drug interactions and probability of target attainment.
    Courlet P; Guidi M; Glatard A; Alves Saldanha S; Cavassini M; Buclin T; Marzolini C; Eap CB; Decosterd LA; Csajka C;
    Br J Clin Pharmacol; 2019 Sep; 85(9):2022-2032. PubMed ID: 31144347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fluoxetine: relations between plasma concentration and therapeutic effects in 32 patients with major depression and treated with 20 mg/day].
    Bourdeaux R; Pannetier P; Younos C; Desor D; Lehr PR; Capolaghi B
    Encephale; 1998; 24(1):57-61. PubMed ID: 9559305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of enteric-coated fluoxetine once-weekly in achieving optimal outcomes in the long-term treatment of depression. Proceedings of a roundtable discussion. October 20, 2000. Los Angeles, California, USA.
    J Clin Psychiatry; 2001; 62 Suppl 22():3-57. PubMed ID: 11686137
    [No Abstract]   [Full Text] [Related]  

  • 8. [Fluoxetine and tricyclic antidepressants: clinical tolerance in short-term combined administration].
    Bonin B; Bertschy G; Baumann P; Francois T; Vandel P; Vandel S; Sechter D; Bizouard P
    Encephale; 1996; 22(3):221-7. PubMed ID: 8767051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nefazodone: a novel antidepressant.
    Goldberg RJ
    Psychiatr Serv; 1995 Nov; 46(11):1113-4. PubMed ID: 8564497
    [No Abstract]   [Full Text] [Related]  

  • 10. Once-weekly fluoxetine.
    Wagstaff AJ; Goa KL
    Drugs; 2001; 61(15):2221-8; discussion 2229-30. PubMed ID: 11772132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind, randomized clinical trial to assess the augmentation with nimodipine of antidepressant therapy in the treatment of "vascular depression".
    Taragano FE; Bagnatti P; Allegri RF
    Int Psychogeriatr; 2005 Sep; 17(3):487-98. PubMed ID: 16252380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy of post-stroke depression with fluoxetine. A pilot project].
    Stamenkovic M; Schindler S; Kasper S
    Nervenarzt; 1996 Jan; 67(1):62-7. PubMed ID: 8676990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute and chronic effects of citalopram on cerebral glucose metabolism in geriatric depression.
    Smith GS; Kramer E; Hermann CR; Goldberg S; Ma Y; Dhawan V; Barnes A; Chaly T; Belakhleff A; Laghrissi-Thode F; Greenwald B; Eidelberg D; Pollock BG
    Am J Geriatr Psychiatry; 2002; 10(6):715-23. PubMed ID: 12427580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decrease of valproic acid concentration in the blood when coprescribed with fluoxetine.
    Droulers A; Bodak N; Oudjhani M; Lefevre des Noettes V; Bodak A
    J Clin Psychopharmacol; 1997 Apr; 17(2):139-40. PubMed ID: 10950492
    [No Abstract]   [Full Text] [Related]  

  • 15. Fluoxetine responsivity mediated by serum levels, not dose.
    Schwartz EM; Markovitz PJ
    J Clin Psychopharmacol; 1993 Oct; 13(5):363-4. PubMed ID: 8227496
    [No Abstract]   [Full Text] [Related]  

  • 16. Multiple-dose pharmacokinetics of fluoxetine in healthy Mexican subjects.
    Carrasco-Portugal MC; Granados-Soto V; Reyes-García G; Medina-Santillán R; Herrera JE; Flores-Murrieta FJ
    Proc West Pharmacol Soc; 2001; 44():69-70. PubMed ID: 11793998
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical studies on event-related potentials (ERPs) N400 and the related factors in patients with poststroke depression (PSD).
    He W; Cai D; Lin L; Fang Y; Zheng X
    Int J Psychiatry Med; 2010; 40(3):349-59. PubMed ID: 21166343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Faster response in depressive patients treated with fluoxetine alone than in combination with buspirone.
    Onder E; Tural U
    J Affect Disord; 2003 Sep; 76(1-3):223-7. PubMed ID: 12943952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lactation associated with fluoxetine treatment.
    Arya DK; Taylor WS
    Aust N Z J Psychiatry; 1995 Dec; 29(4):697. PubMed ID: 8825840
    [No Abstract]   [Full Text] [Related]  

  • 20. Fluoxetine treatment of depressed patients with HIV infection.
    Judd FK; Mijch AM; Cockram A
    Aust N Z J Psychiatry; 1995 Sep; 29(3):433-6. PubMed ID: 8573046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.